Skip to main content

Narumi Nakagiri

Stock Analyst at Daiwa

Total Price Targets
8
Stocks Covered
6
Sectors
Healthcare
Most Recent
Feb 12, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • LLY+15.7%
    Eli Lilly and Company
    $1230.00 targetDec 16, 2025
  • PFE-2.6%
    Pfizer Inc.
    $27.00 targetFeb 12, 2026

Most Bearish

  • PFE-2.6%
    Pfizer Inc.
    $27.00 targetFeb 12, 2026
  • LLY+15.7%
    Eli Lilly and Company
    $1230.00 targetDec 16, 2025

Stocks Covered by Narumi Nakagiri

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
PFEPfizer Inc.$27.00$27.46-1.7%2Feb 12, 2026
LLYEli Lilly and Company$1230.00$1134.50+8.4%2Dec 16, 2025
BMYBristol-Myers Squibb Company$42.00$63.72-34.1%1Aug 5, 2025
ILMNIllumina, Inc.$154.00$223.77-31.2%1Aug 16, 2024
EWEdwards Lifesciences Corporation$72.00$85.82-16.1%1Jul 31, 2024
JNJJohnson & Johnson$150.00$266.07-43.6%1Jul 23, 2024

Recent Activity

  • Feb 12, 2026— Set$27.00price target onPFE(Pfizer Inc.)
  • Dec 16, 2025— Set$1230.00price target onLLY(Eli Lilly and Company)
  • Aug 17, 2025— Set$700.00price target onLLY(Eli Lilly and Company)
  • Aug 5, 2025— Set$42.00price target onBMY(Bristol-Myers Squibb Company)
  • Aug 16, 2024— Set$154.00price target onILMN(Illumina, Inc.)
  • Aug 7, 2024— Set$34.00price target onPFE(Pfizer Inc.)
  • Jul 31, 2024— Set$72.00price target onEW(Edwards Lifesciences Corporation)
  • Jul 23, 2024— Set$150.00price target onJNJ(Johnson & Johnson)

Frequently Asked Questions

Who is Narumi Nakagiri?

Narumi Nakagiri is a stock analyst at Daiwa covering 6 stocks primarily in Healthcare. They have issued 8 price targets since Jul 23, 2024.

What stocks does Narumi Nakagiri cover?

Narumi Nakagiri currently covers 6 stocks, including PFE, LLY, BMY, ILMN, EW.

What is Narumi Nakagiri's latest price target?

Narumi Nakagiri's most recent price target was $27.00 on PFE (Pfizer Inc.), set on Feb 12, 2026.

What is Narumi Nakagiri's highest price target?

Narumi Nakagiri's highest issued price target is $1230.00 on LLY, set on Dec 16, 2025.

Coverage based on publicly published price targets. Not investment advice.